Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

13.9K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.9K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.6K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.6K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.1K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.3K
Ligand Binding Sites02:40

Ligand Binding Sites

13.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.9K
Conserved Binding Sites01:49

Conserved Binding Sites

4.5K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-trained language models for protein and molecular design.

Physical chemistry chemical physics : PCCP·2025
Same author

Multi-objective drug design with a scaffold-aware variational autoencoder.

Chemical science·2025
Same author

A framework reforming personalized Internet of Things by federated meta-learning.

Nature communications·2025
Same author

Dual modality feature fused neural network integrating binding site information for drug target affinity prediction.

NPJ digital medicine·2025
Same author

Knowledge-based inductive bias and domain adaptation for cell type annotation.

Communications biology·2024
Same author

Modal-nexus auto-encoder for multi-modality cellular data integration and imputation.

Nature communications·2024
Same journal

From cyclic diaryl λ<sup>3</sup>-bromanes/chloranes to polyfuntionalized biarylsilanes <i>via</i> aryne σ-bonds.

Chemical science·2026
Same journal

Non-equilibrium formation of the elusive dibridged diboranyl (B<sub>2</sub>H<sub>5</sub>) radical and boranes in low-temperature diborane ices.

Chemical science·2026
Same journal

Visible-light-driven ruthenium-catalyzed hydrogenation of manganese nitride complexes to ammonia under ambient conditions.

Chemical science·2026
Same journal

Quantification of mesopore infiltration in a polymer-grafted metal-organic framework.

Chemical science·2026
Same journal

Enhanced and selective oxygen reduction by iron porphyrin with a biguanide residue in the second coordination sphere.

Chemical science·2026
Same journal

Excited-state orbital angular momentum enables all-optical molecular spin coherence.

Chemical science·2026
See all related articles

Related Experiment Video

Updated: Oct 3, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K

MGraphDTA: deep multiscale graph neural network for explainable drug-target binding affinity prediction.

Ziduo Yang1, Weihe Zhong1, Lu Zhao1,2

  • 1Artificial Intelligence Medical Center, School of Intelligent Systems Engineering, Sun Yat-sen University Shenzhen 510275 China chenyuchian@mail.sysu.edu.cn +862039332153.

Chemical Science
|February 17, 2022
PubMed
Summary
This summary is machine-generated.

A new deep multiscale graph neural network (MGraphDTA) improves drug-target affinity prediction by capturing both local and global compound structures. A novel explanation method (Grad-AAM) provides chemically relevant insights, enhancing model interpretability.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K

Related Experiment Videos

Last Updated: Oct 3, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K

Area of Science:

  • Computational chemistry and cheminformatics
  • Artificial intelligence in drug discovery

Background:

  • Accurate drug-target affinity (DTA) prediction accelerates drug discovery.
  • Graph neural networks (GNNs) are used for DTA prediction, but shallow models struggle with global compound structures.
  • Existing GNN interpretability methods, like graph attention, lack comprehensive global relationship insights.

Purpose of the Study:

  • To develop a deep multiscale graph neural network (MGraphDTA) for enhanced DTA prediction.
  • To improve the capture of both local and global compound structural information.
  • To introduce a novel, chemically intuitive visual explanation method (Grad-AAM) for deep learning models in DTA prediction.

Main Methods:

  • Proposed MGraphDTA, a super-deep GNN with 27 graph convolutional layers and dense connections.
  • Integrated chemical intuition into the GNN architecture for simultaneous local and global structure analysis.
  • Developed Grad-AAM for visual analysis of DTA prediction models from a chemical perspective.

Main Results:

  • MGraphDTA significantly outperformed state-of-the-art deep learning models across seven benchmark datasets.
  • The Grad-AAM method generated explanations consistent with pharmacological knowledge.
  • The approach demonstrated improved generalization and interpretation capabilities in DTA prediction.

Conclusions:

  • The proposed MGraphDTA model offers superior performance in drug-target affinity prediction.
  • Grad-AAM provides valuable chemical insights, aiding in understanding model predictions beyond human perception.
  • This integrated approach enhances both the predictive power and interpretability of computational drug discovery models.